erythro-DL-1-(7-Methylindan-4-yloxy)-3-isopropylaminobutan-2-ol

1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-3-(propan-2-ylamino)-2-butanol

2-Butanol, 1-((2,3-dihydro-7-methyl-1H-inden-4-yl)oxy)-3-((1-methylethyl)amino)-, (R*,S*)-(±)-

2-Butanol, 1-[(2,3-dihydro-7-methyl-1H-inden-4-yl)oxy]-3-[(1-methylethyl)amino]-

3-(Isopropylamino)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-2-butanol

3-(Isopropylamino)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]-2-butanol

3-(Isopropylamino)-1-[(7-méthyl-2,3-dihydro-1H-indén-4-yl)oxy]-2-butanol

3-(Isopropylamino)-1-[(7-methyl-2,3-dihydro-1H-inden-4-yl)oxy]butan-2-ol

erythro-DL-1-(7-Methylindan-4-yloxy)-3-isopropylaminobutan-2-ol

(±)-1-[2,3-(DIHYDRO-[5-3H]-7-METHYL-1H-INDEN-4-YL)OXY]-3-[(1-METHYLETHYL)AMINO]-2-BUTANOL

380610-27-5

5-hydroxytryptamine receptor 1B

5HT1B_RAT

72795-19-8

72795-26-7

ADRB1_HUMAN

ADRB1_RAT

ADRB2_HUMAN

ADRB2_RAT

ADRB3_HUMAN

ICI-118,551

Pertuzumab (anti-HER2)

ZENIDOLOL

β-1 adrenergic receptor

β-2 adrenergic receptor

β-3 adrenergic receptor